These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2859739

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic profile of carvedilol.
    van Zwieten PA.
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [Abstract] [Full Text] [Related]

  • 7. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G, Sampieri L, Cuspidi C, Boselli L, Terzoli L, Rupoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic profile of carvedilol.
    Hombach V, Kochs M, Höher M, Eggeling T, Haerer W, Wieshammer S, Schmidt A.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S101-3. PubMed ID: 1974496
    [Abstract] [Full Text] [Related]

  • 9. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T, Snowden R, Butcher L.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
    Wendt T.
    Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P, Omvik P, Nordrehaug JE, White W.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [Abstract] [Full Text] [Related]

  • 16. Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.
    Nagakawa Y, Akedo Y, Kaku S, Orimo H.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S115-9. PubMed ID: 1974500
    [Abstract] [Full Text] [Related]

  • 17. Effect of carvedilol on left ventricular function and mass in hypertension.
    Why HJ, Richardson PJ.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S50-4. PubMed ID: 1378151
    [Abstract] [Full Text] [Related]

  • 18. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.